Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Research Report 2022

Publisher Name :
Date: 17-Aug-2022
No. of pages: 88
Inquire Before Buying

Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Transthyretin Stabilizers

- Nonsteroidal Anti-inflammatory Drugs (NSAID)

- RNAi Therapy

- Others

Segment by Application

- Hereditary Transthyretin Amyloidosis (hATTR)

- Wild Type Transthyretin Amyloidosis (wtATTR)

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Pfizer Inc

- GlaxoSmithKline Plc

- Eidos Therapeutics

- Ionis Pharmaceuticals, Inc

- Alnylam Pharmaceuticals

- Prothena Corporation Plc

- Intellia Therapeutics, Inc

- Corino Therapeutics, Inc

Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Transthyretin Stabilizers
1.2.3 Nonsteroidal Anti-inflammatory Drugs (NSAID)
1.2.4 RNAi Therapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hereditary Transthyretin Amyloidosis (hATTR)
1.3.3 Wild Type Transthyretin Amyloidosis (wtATTR)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Perspective (2017-2028)
2.2 Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Growth Trends by Region
2.2.1 Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Historic Market Size by Region (2017-2022)
2.2.3 Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Forecasted Market Size by Region (2023-2028)
2.3 Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Dynamics
2.3.1 Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Industry Trends
2.3.2 Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Drivers
2.3.3 Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Challenges
2.3.4 Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Players by Revenue
3.1.1 Global Top Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Players by Revenue (2017-2022)
3.1.2 Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Revenue
3.4 Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Concentration Ratio
3.4.1 Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Revenue in 2021
3.5 Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Key Players Head office and Area Served
3.6 Key Players Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Product Solution and Service
3.7 Date of Enter into Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Breakdown Data by Type
4.1 Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Historic Market Size by Type (2017-2022)
4.2 Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Forecasted Market Size by Type (2023-2028)
5 Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Breakdown Data by Application
5.1 Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Historic Market Size by Application (2017-2022)
5.2 Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size (2017-2028)
6.2 North America Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size by Country (2017-2022)
6.3 North America Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size (2017-2028)
7.2 Europe Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size by Country (2017-2022)
7.3 Europe Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size (2017-2028)
8.2 Asia-Pacific Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size by Country (2017-2022)
8.3 Asia-Pacific Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size (2017-2028)
9.2 Latin America Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size by Country (2017-2022)
9.3 Latin America Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size (2017-2028)
10.2 Middle East & Africa Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size by Country (2017-2022)
10.3 Middle East & Africa Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Pfizer Inc
11.1.1 Pfizer Inc Company Detail
11.1.2 Pfizer Inc Business Overview
11.1.3 Pfizer Inc Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Introduction
11.1.4 Pfizer Inc Revenue in Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Business (2017-2022)
11.1.5 Pfizer Inc Recent Development
11.2 GlaxoSmithKline Plc
11.2.1 GlaxoSmithKline Plc Company Detail
11.2.2 GlaxoSmithKline Plc Business Overview
11.2.3 GlaxoSmithKline Plc Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Introduction
11.2.4 GlaxoSmithKline Plc Revenue in Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Business (2017-2022)
11.2.5 GlaxoSmithKline Plc Recent Development
11.3 Eidos Therapeutics
11.3.1 Eidos Therapeutics Company Detail
11.3.2 Eidos Therapeutics Business Overview
11.3.3 Eidos Therapeutics Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Introduction
11.3.4 Eidos Therapeutics Revenue in Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Business (2017-2022)
11.3.5 Eidos Therapeutics Recent Development
11.4 Ionis Pharmaceuticals, Inc
11.4.1 Ionis Pharmaceuticals, Inc Company Detail
11.4.2 Ionis Pharmaceuticals, Inc Business Overview
11.4.3 Ionis Pharmaceuticals, Inc Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Introduction
11.4.4 Ionis Pharmaceuticals, Inc Revenue in Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Business (2017-2022)
11.4.5 Ionis Pharmaceuticals, Inc Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Detail
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Business (2017-2022)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Prothena Corporation Plc
11.6.1 Prothena Corporation Plc Company Detail
11.6.2 Prothena Corporation Plc Business Overview
11.6.3 Prothena Corporation Plc Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Introduction
11.6.4 Prothena Corporation Plc Revenue in Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Business (2017-2022)
11.6.5 Prothena Corporation Plc Recent Development
11.7 Intellia Therapeutics, Inc
11.7.1 Intellia Therapeutics, Inc Company Detail
11.7.2 Intellia Therapeutics, Inc Business Overview
11.7.3 Intellia Therapeutics, Inc Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Introduction
11.7.4 Intellia Therapeutics, Inc Revenue in Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Business (2017-2022)
11.7.5 Intellia Therapeutics, Inc Recent Development
11.8 Corino Therapeutics, Inc
11.8.1 Corino Therapeutics, Inc Company Detail
11.8.2 Corino Therapeutics, Inc Business Overview
11.8.3 Corino Therapeutics, Inc Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Introduction
11.8.4 Corino Therapeutics, Inc Revenue in Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Business (2017-2022)
11.8.5 Corino Therapeutics, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Transthyretin Stabilizers
Table 3. Key Players of Nonsteroidal Anti-inflammatory Drugs (NSAID)
Table 4. Key Players of RNAi Therapy
Table 5. Key Players of Others
Table 6. Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Share by Region (2017-2022)
Table 10. Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Share by Region (2023-2028)
Table 12. Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Trends
Table 13. Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Drivers
Table 14. Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Challenges
Table 15. Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Restraints
Table 16. Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Share by Players (2017-2022)
Table 18. Global Top Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment as of 2021)
Table 19. Ranking of Global Top Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Product Solution and Service
Table 23. Date of Enter into Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Revenue Market Share by Type (2017-2022)
Table 27. Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Revenue Market Share by Type (2023-2028)
Table 29. Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Revenue Market Share by Application (2017-2022)
Table 31. Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Revenue Market Share by Application (2023-2028)
Table 33. North America Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 43. Pfizer Inc Company Detail
Table 44. Pfizer Inc Business Overview
Table 45. Pfizer Inc Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Product
Table 46. Pfizer Inc Revenue in Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Business (2017-2022) & (US$ Million)
Table 47. Pfizer Inc Recent Development
Table 48. GlaxoSmithKline Plc Company Detail
Table 49. GlaxoSmithKline Plc Business Overview
Table 50. GlaxoSmithKline Plc Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Product
Table 51. GlaxoSmithKline Plc Revenue in Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Business (2017-2022) & (US$ Million)
Table 52. GlaxoSmithKline Plc Recent Development
Table 53. Eidos Therapeutics Company Detail
Table 54. Eidos Therapeutics Business Overview
Table 55. Eidos Therapeutics Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Product
Table 56. Eidos Therapeutics Revenue in Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Business (2017-2022) & (US$ Million)
Table 57. Eidos Therapeutics Recent Development
Table 58. Ionis Pharmaceuticals, Inc Company Detail
Table 59. Ionis Pharmaceuticals, Inc Business Overview
Table 60. Ionis Pharmaceuticals, Inc Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Product
Table 61. Ionis Pharmaceuticals, Inc Revenue in Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Business (2017-2022) & (US$ Million)
Table 62. Ionis Pharmaceuticals, Inc Recent Development
Table 63. Alnylam Pharmaceuticals Company Detail
Table 64. Alnylam Pharmaceuticals Business Overview
Table 65. Alnylam Pharmaceuticals Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Product
Table 66. Alnylam Pharmaceuticals Revenue in Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Business (2017-2022) & (US$ Million)
Table 67. Alnylam Pharmaceuticals Recent Development
Table 68. Prothena Corporation Plc Company Detail
Table 69. Prothena Corporation Plc Business Overview
Table 70. Prothena Corporation Plc Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Product
Table 71. Prothena Corporation Plc Revenue in Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Business (2017-2022) & (US$ Million)
Table 72. Prothena Corporation Plc Recent Development
Table 73. Intellia Therapeutics, Inc Company Detail
Table 74. Intellia Therapeutics, Inc Business Overview
Table 75. Intellia Therapeutics, Inc Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Product
Table 76. Intellia Therapeutics, Inc Revenue in Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Business (2017-2022) & (US$ Million)
Table 77. Intellia Therapeutics, Inc Recent Development
Table 78. Corino Therapeutics, Inc Company Detail
Table 79. Corino Therapeutics, Inc Business Overview
Table 80. Corino Therapeutics, Inc Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Product
Table 81. Corino Therapeutics, Inc Revenue in Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Business (2017-2022) & (US$ Million)
Table 82. Corino Therapeutics, Inc Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Share by Type: 2021 VS 2028
Figure 2. Transthyretin Stabilizers Features
Figure 3. Nonsteroidal Anti-inflammatory Drugs (NSAID) Features
Figure 4. RNAi Therapy Features
Figure 5. Others Features
Figure 6. Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Share by Application in 2021 & 2028
Figure 7. Hereditary Transthyretin Amyloidosis (hATTR) Case Studies
Figure 8. Wild Type Transthyretin Amyloidosis (wtATTR) Case Studies
Figure 9. Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Report Years Considered
Figure 10. Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Share by Region: 2021 VS 2028
Figure 13. Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Share by Players in 2021
Figure 14. Global Top Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Revenue in 2021
Figure 16. North America Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Share by Country (2017-2028)
Figure 18. United States Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Share by Country (2017-2028)
Figure 22. Germany Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Share by Region (2017-2028)
Figure 30. China Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Share by Country (2017-2028)
Figure 38. Mexico Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Share by Country (2017-2028)
Figure 42. Turkey Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Pfizer Inc Revenue Growth Rate in Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Business (2017-2022)
Figure 45. GlaxoSmithKline Plc Revenue Growth Rate in Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Business (2017-2022)
Figure 46. Eidos Therapeutics Revenue Growth Rate in Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Business (2017-2022)
Figure 47. Ionis Pharmaceuticals, Inc Revenue Growth Rate in Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Business (2017-2022)
Figure 48. Alnylam Pharmaceuticals Revenue Growth Rate in Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Business (2017-2022)
Figure 49. Prothena Corporation Plc Revenue Growth Rate in Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Business (2017-2022)
Figure 50. Intellia Therapeutics, Inc Revenue Growth Rate in Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Business (2017-2022)
Figure 51. Corino Therapeutics, Inc Revenue Growth Rate in Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Business (2017-2022)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
  • Global Spine Surgery Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Oct-2022        Price: US 5600 Onwards        Pages: 110
    Report Scope This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Spine Surgery companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, th......
  • Global Sperm Analyzer Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Oct-2022        Price: US 5600 Onwards        Pages: 102
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Sperm Analyzer manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publi......
  • Global Single-Photon Emission Computed Tomography (SPECT) Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Oct-2022        Price: US 5600 Onwards        Pages: 113
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Single-Photon Emission Computed Tomography (SPECT) manufacturers, distributors, end users, industry associations, governmen......
  • Global Hybrid Contact Lenses Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Oct-2022        Price: US 5600 Onwards        Pages: 128
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Hybrid Contact Lenses manufacturers, distributors, end users, industry associations, governments' industry bureaus, industr......
  • Global Snoring Control Devices Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Oct-2022        Price: US 5600 Onwards        Pages: 116
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Snoring Control Devices manufacturers, distributors, end users, industry associations, governments' industry bureaus, indus......
  • Global Smart Wearable Healthcare Devices Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Oct-2022        Price: US 5600 Onwards        Pages: 111
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Smart Wearable Healthcare Devices manufacturers, distributors, end users, industry associations, governments' industry bure......
  • Global Smart Inhaler Technology Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Oct-2022        Price: US 5600 Onwards        Pages: 107
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Smart Inhaler Technology manufacturers, distributors, end users, industry associations, governments' industry bureaus, indu......
  • Global Expressed Competent Cells Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Oct-2022        Price: US 5600 Onwards        Pages: 116
    Report Scope This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Expressed Competent Cells companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry......
  • Global Cloned Competent Cells Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 05-Oct-2022        Price: US 5600 Onwards        Pages: 121
    Report Scope This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Cloned Competent Cells companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry ex......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs